“The quality of our lives depends on the quality of our minds.” At first glance, that statement feels obvious. But if you’ve ever struggled with depression, anxiety, or relentless self-criticism, you know something deeper: our minds don’t always feel like places we can choose to inhabit.
Sometimes they become prisons.
The same thoughts echo through our consciousness day after day. The same fears replay. The same stories become so familiar that we stop recognizing them as stories at all. They become reality. The pressure of functioning in a society that many (myself included) feel to be way out of alignment with fundamental values of being human spiritual beings, grows and grows while we do our best to navigate life.
For decades, modern psychiatry has worked to ease this suffering through medications known as Selective Serotonin Reuptake Inhibitors, or SSRIs. Medications like Prozac, Lexapro, Zoloft, Celexa, and Paxil have helped millions of people reclaim stability, rebuild relationships, and find relief from depression and anxiety for periods of time. However, with prolonged use, dependency, dosage increases, and other factors often play into these prescriptions.
More recently, another path has captured the attention of neuroscientists, psychologists, and clinicians around the world.
Psilocybin <3
The naturally occurring psychedelic compound found in certain mushrooms has become one of the most promising areas of mental health research because modern science is finally beginning to understand what many Indigenous traditions have known for generations: that altered states of consciousness, when approached with reverence and proper support, can become catalysts for profound healing.
Although SSRIs and psilocybin both seek to reduce suffering, they represent two fundamentally different philosophies of healing.
One gradually alters brain chemistry over time.
The other appears to temporarily alter the way the brain communicates with itself.
Understanding this distinction changes the conversation entirely.
Instead of asking, “Which one is better?”, perhaps we should begin asking a more thoughtful question:
What kind of healing does this particular person need, at this particular moment in their life?
SSRIs: We are talking medications such as Zoloft (sertraline), Prozac (fluoxetine), Lexapro (escitalopram), Celexa (citalopram), and Paxil (paroxetine) work by increasing the availability of serotonin in the brain by blocking its reabsorption. Taken daily, they often require several weeks before noticeable improvements occur. For millions of people, these medications have been life-changing (for a period of time), yet they are not without limitations.
Some individuals find that after months or years of treatment, their symptoms gradually return. Dosage adjustments often, increases become necessary, this highlights that SSRIs are not a universal or permanent solution for everyone. Another commonly discussed concern is emotional blunting. While reducing emotional pain can be profoundly beneficial, many long-term SSRI users also describe feeling emotionally muted, as though joy, excitement, creativity, and emotional depth become softened alongside sadness and anxiety.
This makes so much sense if you think about it. As we deepen into our understanding of what it means to exist in a totally interconnected world where all parts of ourselves are in communication with one another and our surrounding, it becomes apparent that all parts of the spectrum affect one another.
It’s also important to acknowledge that getting off SSRIs isn’t as simple as stopping a medication. Safe discontinuation generally requires a gradual taper under medical supervision, and many people experience withdrawal or discontinuation symptoms, making it a challenging process both mentally and physically.
Psilocybin works through an entirely different mechanism. After ingestion, it is converted into psilocin, which primarily activates the brain’s serotonin 5-HT2A receptors. Rather than simply increasing serotonin levels, psilocybin appears to temporarily reorganize communication between brain networks.
Functional MRI studies have shown decreased activity in the brain’s Default Mode Network (DMN), a network associated with self-referential thinking, rumination, and rigid thought patterns. This temporary reduction in DMN activity may help explain why many participants describe experiences of expanded awareness, increased psychological flexibility, and a diminished sense of ego.
Perhaps one of the most fascinating discoveries emerging from psychedelic research is psilocybin’s apparent ability to promote neuroplasticity, the brain’s remarkable capacity to form new neural connections.
Let’s take a collective pause for a moment and really consider what that means.
We’re talking about the possibility that the brain can temporarily become more capable of developing entirely new ways of organizing thought, emotion, and behavior. For someone who has spent years trapped in cycles of depression, anxiety, trauma, or self-criticism, that possibility is extraordinary.
Laboratory research suggests psychedelics may stimulate dendritic growth, strengthen synaptic connections, and encourage the formation of new neural pathways involved in learning and emotional adaptation. In simple terms, the brain may become temporarily more receptive to change, allowing individuals to loosen deeply ingrained psychological patterns that once felt impossible to escape.
Clinical research has produced similarly encouraging findings.
Studies conducted at Johns Hopkins University, Imperial College London, and New York University have demonstrated significant reductions in symptoms of treatment-resistant depression, major depressive disorder, end-of-life anxiety, addiction, and existential distress following carefully supervised psilocybin-assisted therapy. Perhaps most remarkably, several studies have found that meaningful improvements persisted for months, sometimes years after only one or two guided sessions when paired with psychotherapy and intentional integration.
This differs substantially from SSRIs, which generally require continuous daily use to maintain their therapeutic effects.
Where SSRIs often aim to reduce the intensity of difficult emotions, psilocybin frequently appears to amplify emotional processing during the experience itself. Previously avoided memories, grief, fears, and insights may surface not as a side effect, but as part of the therapeutic process. This intensity is precisely why preparation, professional guidance, and thoughtful integration remain essential components of psychedelic therapy.
As enthusiasm around psychedelics grows, it’s equally important to remain honest about antidepressants. SSRIs have helped millions of people; that is true.
But another truth deserves our attention as well.
In 2008, researchers led by Dr. Erick Turner published a landmark analysis in the New England Journal of Medicine examining every antidepressant trial submitted to the U.S. Food and Drug Administration, not just the ones that were published.
What they found sparked an ongoing conversation about transparency in medical research.
Nearly all of the positive studies eventually appeared in scientific journals.
Many of the negative or inconclusive studies did not.
As a result, someone reading only the published literature would have concluded that 94% of antidepressant trials produced positive results.
When researchers examined the complete FDA dataset, however, only about 51% of the trials were actually positive. The authors concluded that selective publication had created an inflated impression of antidepressant effectiveness.
That means the public and even physicians were seeing an incomplete picture.
A second influential analysis by psychologist Dr. Irving Kirsch reached another important conclusion.
When FDA trial data were examined in full, antidepressants appeared to provide the greatest benefit for people experiencing severe depression, while the average advantage over placebo was considerably smaller for many people with mild to moderate depression.
These findings invite us to ask important questions about how commercialized approaches to healing are presented to the public – particularly when multibillion-dollar pharmaceutical companies have significant influence over research, marketing, and public perception. This doesn’t mean SSRIs are ineffective; rather, it suggests that understanding their true benefits requires looking beyond published studies alone and considering the complete body of evidence.
One of the greatest mistakes we make is assuming that healing must belong to one camp.
Pharmaceutical.
Natural.
Ancient.
Modern.
Science.
Spirit.
The human nervous system has never been that simple.
Someone living in profound depression may first need the stability an SSRI provides simply to begin functioning again.
Another person may reach a place where carefully supported psychedelic therapy helps them finally process grief they’ve carried for decades.
Someone else may benefit from both (or neither).
Alongside psychotherapy.
Exercise.
Meditation.
Nutrition.
Sleep.
Purpose.
No single intervention carries the entire weight of healing.
Nor should it.
Perhaps the future of mental health won’t belong exclusively to pharmaceuticals.
Nor will it belong exclusively to psychedelics.
It will belong to curiosity.
To humility.
To the willingness to admit that the human mind is far more mysterious and far more adaptable than we once believed.
To suffer a little less.
To feel a little more alive.
To remember that we are not the stories our minds have rehearsed for years.
We are something far more dynamic than that.
The more neuroscience uncovers about the remarkable plasticity of the human brain, the more it echoes a truth that contemplative traditions have whispered for centuries:
Transformation is possible.
Disclaimer: This article is intended for educational purposes only and is not a substitute for medical advice. Never discontinue or adjust prescribed medications without consulting your prescribing physician.
References
Rewards
Invite your friends and earn a discount on your next purchase. Your friend also earns a discount! Get started now, by sharing your referral link with your friends.
Invite your friends and earn a discount on your next purchase. Your friend also earns a discount! Get started now, by sharing your referral link with your friends.
This item is currently out of stock!
By adding it to your cart, you confirm a backorder purchase, and we will ship it as soon as it becomes available.
